• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非酒精性慢性肝脏疾病患者中,简短的酒精干预措施未得到充分利用。

Brief alcohol interventions are underutilized in persons with nonalcohol-associated chronic liver diseases.

机构信息

Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Hepatol Commun. 2024 Apr 3;8(4). doi: 10.1097/HC9.0000000000000420. eCollection 2024 Apr 1.

DOI:10.1097/HC9.0000000000000420
PMID:38563583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10990407/
Abstract

BACKGROUND

Brief alcohol interventions use patient-provider communication to promote alcohol cessation. We characterized the receipt of this intervention in chronic liver disease (CLD).

METHODS

We surveyed patients with CLD for weekly drinking patterns and examined associations with patient-provider communication receipt.

RESULTS

Among 840 participants, 82.1% and 56.5% reported ≥1 standard drink weekly and excessive alcohol consumption, respectively. Patient-provider communication was lower in noncirrhotic (adjusted odds ratio:0.34, 95% CI: 0.22-0.54) and nonalcohol-associated CLD (adjusted odds ratio: 0.22, 95% CI: 0.15-0.34) among individuals drinking ≥1 standard drink weekly, and similarly in noncirrhotic CLD (adjusted odds ratio: 0.45, 95% CI: 0.21-0.95) among those with excessive drinking.

CONCLUSIONS

Brief alcohol interventions are underutilized in noncirrhotic and nonalcohol-associated CLD.

摘要

背景

简短的酒精干预措施利用医患沟通来促进戒酒。我们描述了慢性肝病(CLD)中接受这种干预的情况。

方法

我们调查了 CLD 患者的每周饮酒模式,并研究了与接受医患沟通之间的关联。

结果

在 840 名参与者中,分别有 82.1%和 56.5%的人报告每周至少饮用 1 标准杯和过量饮酒。每周至少饮用 1 标准杯的非肝硬化(调整后的优势比:0.34,95%CI:0.22-0.54)和非酒精相关 CLD(调整后的优势比:0.22,95%CI:0.15-0.34)患者中,医患沟通较少,而非肝硬化 CLD 患者(调整后的优势比:0.45,95%CI:0.21-0.95)中过量饮酒者也存在同样情况。

结论

在非肝硬化和非酒精相关 CLD 中,简短的酒精干预措施的使用不足。

相似文献

1
Brief alcohol interventions are underutilized in persons with nonalcohol-associated chronic liver diseases.在非酒精性慢性肝脏疾病患者中,简短的酒精干预措施未得到充分利用。
Hepatol Commun. 2024 Apr 3;8(4). doi: 10.1097/HC9.0000000000000420. eCollection 2024 Apr 1.
2
Are There Sex Differences in the Association of Alcohol Consumption With the Risk of Soft Tissue Sarcoma? A Nationwide Population-based Study in Korea.饮酒与软组织肉瘤风险之间的关联存在性别差异吗?韩国一项基于全国人口的研究。
Clin Orthop Relat Res. 2025 Jun 25. doi: 10.1097/CORR.0000000000003602.
3
Effectiveness of brief alcohol interventions in primary care populations.简短酒精干预措施在初级保健人群中的有效性。
Cochrane Database Syst Rev. 2018 Feb 24;2(2):CD004148. doi: 10.1002/14651858.CD004148.pub4.
4
Personalised digital interventions for reducing hazardous and harmful alcohol consumption in community-dwelling populations.针对社区居住人群减少有害和危险饮酒行为的个性化数字干预措施。
Cochrane Database Syst Rev. 2017 Sep 25;9(9):CD011479. doi: 10.1002/14651858.CD011479.pub2.
5
Interventions for tobacco use cessation in people living with HIV.HIV 感染者的戒烟干预措施。
Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3.
6
Interventions implemented through sporting organisations for promoting healthy behaviour or improving health outcomes.体育组织为促进健康行为或改善健康结果而实施的干预措施。
Cochrane Database Syst Rev. 2025 Jan 13;1(1):CD012170. doi: 10.1002/14651858.CD012170.pub2.
7
Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco.用于改变食品、酒精饮料和烟草的选择及消费量的份量、包装或餐具尺寸。
Cochrane Database Syst Rev. 2015 Sep 14;2015(9):CD011045. doi: 10.1002/14651858.CD011045.pub2.
8
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders.针对正在接受物质使用障碍治疗或已康复的人群的戒烟干预措施。
Cochrane Database Syst Rev. 2016 Nov 23;11(11):CD010274. doi: 10.1002/14651858.CD010274.pub2.
9
Baclofen for alcohol use disorder.巴氯芬治疗酒精使用障碍。
Cochrane Database Syst Rev. 2023 Jan 13;1(1):CD012557. doi: 10.1002/14651858.CD012557.pub3.
10
Social norms information for alcohol misuse in university and college students.针对大学生酒精滥用问题的社会规范信息。
Cochrane Database Syst Rev. 2015 Jan 26;1:CD006748. doi: 10.1002/14651858.CD006748.pub3.

引用本文的文献

1
Telemedicine Approaches for Patients with Cirrhosis, Including Vulnerable Populations: A Narrative Review.针对肝硬化患者(包括弱势群体)的远程医疗方法:一项叙述性综述。
Can Liver J. 2025 Apr 2;8(2):329-343. doi: 10.3138/canlivj-2025-0008. eCollection 2025 May.
2
Racial Disparities of Alcohol-Associated Liver Disease and Its Complications in Hospitalized Patients With Alcohol Use Disorder.酒精使用障碍住院患者中酒精性肝病及其并发症的种族差异
Gastro Hep Adv. 2024 Nov 29;4(4):100592. doi: 10.1016/j.gastha.2024.100592. eCollection 2025.

本文引用的文献

1
Improving alcohol treatment engagement using integrated behavioral interventions in alcohol-associated liver disease: A randomized pilot trial.利用综合行为干预提高酒精相关性肝病患者的酒精治疗参与度:一项随机试点试验。
Hepatol Commun. 2023 Sep 15;7(10). doi: 10.1097/HC9.0000000000000181. eCollection 2023 Oct 1.
2
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
3
Contribution of a genetic risk score to ethnic differences in fatty liver disease.
遗传风险评分对脂肪肝疾病的种族差异的贡献。
Liver Int. 2022 Oct;42(10):2227-2236. doi: 10.1111/liv.15322. Epub 2022 Jun 6.
4
Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors.减少可能增加肝性脑病风险的药物:一项对肝硬化患者及其医生的定性研究。
United European Gastroenterol J. 2021 Mar;9(2):193-202. doi: 10.1177/2050640620975224. Epub 2021 Feb 18.
5
Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.在脂肪肝疾病中,轻度和中度饮酒的风险:人群队列的随访。
Hepatology. 2020 Mar;71(3):835-848. doi: 10.1002/hep.30864. Epub 2019 Oct 8.
6
Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.酒精性肝病的诊断与治疗:美国肝病研究协会2019年实践指南
Hepatology. 2020 Jan;71(1):306-333. doi: 10.1002/hep.30866.
7
Effectiveness of brief alcohol interventions in primary care populations.简短酒精干预措施在初级保健人群中的有效性。
Cochrane Database Syst Rev. 2018 Feb 24;2(2):CD004148. doi: 10.1002/14651858.CD004148.pub4.
8
Brief interventions for alcohol misuse.针对酒精滥用的简短干预措施。
CMAJ. 2015 Apr 21;187(7):502-506. doi: 10.1503/cmaj.140254. Epub 2015 Mar 2.
9
Increased documented brief alcohol interventions with a performance measure and electronic decision support.增加有绩效测量和电子决策支持的记录简短酒精干预。
Med Care. 2012 Feb;50(2):179-87. doi: 10.1097/MLR.0b013e3181e35743.
10
A cross-national trial of brief interventions with heavy drinkers. WHO Brief Intervention Study Group.一项针对重度饮酒者的简短干预措施的跨国试验。世界卫生组织简短干预研究小组。
Am J Public Health. 1996 Jul;86(7):948-55. doi: 10.2105/ajph.86.7.948.